[go: up one dir, main page]

PL3452053T3 - Sposób leczenia urotelialnego nowotworu złośliwego dolnych dróg - Google Patents

Sposób leczenia urotelialnego nowotworu złośliwego dolnych dróg

Info

Publication number
PL3452053T3
PL3452053T3 PL17793523.6T PL17793523T PL3452053T3 PL 3452053 T3 PL3452053 T3 PL 3452053T3 PL 17793523 T PL17793523 T PL 17793523T PL 3452053 T3 PL3452053 T3 PL 3452053T3
Authority
PL
Poland
Prior art keywords
urothelial cancer
treating lower
lower tract
tract urothelial
treating
Prior art date
Application number
PL17793523.6T
Other languages
English (en)
Inventor
Dennis GIESING
Christopher CUTIE
Purnanand SARMA
Cheryl Larrivee-Elkins
Christopher SEARCY
Vikas Agarwal
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Publication of PL3452053T3 publication Critical patent/PL3452053T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL17793523.6T 2016-05-06 2017-05-05 Sposób leczenia urotelialnego nowotworu złośliwego dolnych dróg PL3452053T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662333151P 2016-05-06 2016-05-06
US201762443614P 2017-01-06 2017-01-06
PCT/US2017/031445 WO2017193098A1 (en) 2016-05-06 2017-05-05 Method of treating lower tract urothelial cancer

Publications (1)

Publication Number Publication Date
PL3452053T3 true PL3452053T3 (pl) 2023-05-08

Family

ID=60203435

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17793523.6T PL3452053T3 (pl) 2016-05-06 2017-05-05 Sposób leczenia urotelialnego nowotworu złośliwego dolnych dróg

Country Status (23)

Country Link
US (1) US20190388338A1 (pl)
EP (2) EP3452053B1 (pl)
JP (3) JP7712055B2 (pl)
KR (2) KR20220123317A (pl)
CN (2) CN118453872A (pl)
AU (1) AU2017261371B2 (pl)
CA (1) CA3023274A1 (pl)
ES (1) ES2940227T3 (pl)
FI (1) FI3452053T3 (pl)
HR (1) HRP20221544T1 (pl)
HU (1) HUE060965T2 (pl)
IL (2) IL295592A (pl)
LT (1) LT3452053T (pl)
MX (2) MX389296B (pl)
NZ (3) NZ748252A (pl)
PL (1) PL3452053T3 (pl)
PT (1) PT3452053T (pl)
RS (1) RS64032B1 (pl)
RU (2) RU2022100624A (pl)
SG (2) SG10201913416PA (pl)
SI (1) SI3452053T1 (pl)
SM (1) SMT202300047T1 (pl)
WO (1) WO2017193098A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2908376T3 (es) 2015-11-03 2022-04-28 Janssen Biotech Inc Anticuerpos que se unen específicamente a PD-1 y usos de los mismos
US10844119B2 (en) 2016-10-11 2020-11-24 Agenus Inc. Anti-LAG-3 antibodies and methods of use thereof
SG10201913998YA (en) * 2017-07-25 2020-03-30 Taris Biomedical Llc Methods of treating tumor metastasis
SG11202003950WA (en) 2017-11-08 2020-05-28 Taris Biomedical Llc Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
US12398209B2 (en) 2018-01-22 2025-08-26 Janssen Biotech, Inc. Methods of treating cancers with antagonistic anti-PD-1 antibodies

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30915A1 (es) * 2007-02-16 2008-09-02 Smithkline Beecham Corp Método de tratamiento de canceres
EA023156B1 (ru) 2009-06-26 2016-04-29 ТАРИС Биомедикал ЛЛК Устройство для доставки лекарств
DK2512581T3 (da) 2009-12-17 2021-03-29 Taris Biomedical Llc Implanterbar indretning med intravesikal tolerance
BR112012030699A2 (pt) * 2010-06-02 2016-09-13 Abraxis Bioscience Llc métodos para tratar câncer de bexiga
SI2600800T1 (sl) 2010-08-05 2021-03-31 Taris Biomedical Llc Naprava za dovajanje zdravila preko sečevodnega stenta in komplet
ES2637388T3 (es) 2011-02-04 2017-10-13 Taris Biomedical, Inc. Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad
KR20190134832A (ko) * 2012-03-29 2019-12-04 알토 바이오사이언스 코포레이션 종양 형성 치료방법
HUE056976T2 (hu) * 2012-08-31 2022-04-28 Taris Biomedical Llc Gyógyszeradagoló rendszer és eljárás hólyagrák kezelésére oxaliplatinnal
CA2882575C (en) 2012-08-31 2020-05-26 Dennis GIESING Drug delivery systems and methods for treatment of prostate
US10137287B2 (en) 2013-03-05 2018-11-27 Taris Biomedical Llc Drug delivery devices and methods for controlled drug release through device orifice
AU2014227914B2 (en) 2013-03-15 2018-05-10 Taris Biomedical Llc Drug delivery devices and methods for drug delivery
CN105163794B (zh) 2013-03-15 2020-03-27 塔里斯生物医药公司 具有药物可渗透部件的药物递送装置和方法
EP4234036A3 (en) 2013-08-19 2023-11-01 TARIS Biomedical LLC Multi-unit drug delivery devices
KR102338079B1 (ko) * 2014-03-06 2021-12-09 타리스 바이오메디컬 엘엘씨 젬시타빈으로 방광암을 치료하기 위한 약물 전달 시스템 및 방법
DK3160442T3 (da) 2014-06-26 2019-06-11 Taris Biomedical Llc Indretninger og fremgangsmåder til intravesical lægemiddelafgivelse omfattende matrixsystemer af elastisk polymer med lægemiddel
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法

Also Published As

Publication number Publication date
EP3452053A4 (en) 2019-12-25
KR20220123317A (ko) 2022-09-06
MX2018013432A (es) 2019-08-12
US20190388338A1 (en) 2019-12-26
CN109475571A (zh) 2019-03-15
PT3452053T (pt) 2023-03-03
MX389296B (es) 2025-03-20
RS64032B1 (sr) 2023-04-28
SI3452053T1 (sl) 2023-03-31
EP3452053A1 (en) 2019-03-13
CA3023274A1 (en) 2017-11-09
RU2018142908A (ru) 2020-06-08
NZ787786A (en) 2025-10-31
IL295592A (en) 2022-10-01
IL262746A (en) 2018-12-31
HRP20221544T1 (hr) 2023-02-17
BR112018072551A2 (pt) 2019-02-19
AU2017261371B2 (en) 2023-07-06
AU2017261371A1 (en) 2018-12-13
EP3452053B1 (en) 2022-12-14
CN118453872A (zh) 2024-08-09
MX2021013461A (es) 2021-12-10
WO2017193098A1 (en) 2017-11-09
JP2024028881A (ja) 2024-03-05
KR20190005204A (ko) 2019-01-15
EP4209221A1 (en) 2023-07-12
HUE060965T2 (hu) 2023-04-28
RU2022100624A (ru) 2022-02-09
SG10201913416PA (en) 2020-03-30
RU2764747C2 (ru) 2022-01-20
FI3452053T3 (fi) 2023-04-12
SMT202300047T1 (it) 2023-03-17
SG11201809838VA (en) 2018-12-28
KR102435709B1 (ko) 2022-08-25
ES2940227T3 (es) 2023-05-04
LT3452053T (lt) 2023-02-10
NZ748252A (en) 2025-10-31
JP7712055B2 (ja) 2025-07-23
JP2019514970A (ja) 2019-06-06
IL262746B (en) 2022-09-01
NZ787824A (en) 2025-10-31
RU2018142908A3 (pl) 2020-08-31
JP2022009327A (ja) 2022-01-14

Similar Documents

Publication Publication Date Title
IL275663A (en) Cancer treatment methods
IL263925A (en) Methods of treating ovarian cancer
ZA201804227B (en) Methods of treating cancer
IL255189A0 (en) Cancer treatment methods
IL255569A (en) Methods of treating cancer using anti-ox40 antibodies
HUE052106T2 (hu) Eljárás rák kezelésére
SG11201607130RA (en) Combination method for treatment of cancer
IL262342A (en) Cancer treatment methods
IL262005A (en) Methods of treating cancer in children
ZA201808258B (en) Methods of treating pancreatic cancer
ZA201802481B (en) Novel biomarkers and methods of treating cancer
IL262746A (en) A method for treating urothelial cancer in the lower system
ZA201908539B (en) Method of treatment of cancer
IL263835A (en) Exosome-guided treatment of cancer
GB201717945D0 (en) Method for treatment of cancer
SG11202005163PA (en) Methods of treating cancer
IL269123A (en) Methods of treating cancer
GB201510197D0 (en) Method of treating ovarian cancer
GB201622214D0 (en) treatment of cancer
GB201604621D0 (en) Treatment of cancer
GB201604293D0 (en) Treatment of cancer